Avi Avramoff

Title: Avi Avramoff: Innovator in Topical Formulations

Introduction

Avi Avramoff is a notable inventor based in Haifa, Israel, recognized for his contributions to pharmaceutical formulations. With a total of 14 patents to his name, he has made significant strides in the field of topical medications.

Latest Patents

Avramoff's latest patents focus on topical Montelukast formulations. One of his innovations includes a topical emulsion that comprises about 0.5% to about 10% Montelukast or its pharmaceutically acceptable salt, along with about 0.4% to about 4% carbomer. The emulsion is designed to have particles with a D90 of less than about 50 μm, ensuring that the Montelukast is homogeneously dispersed. Additionally, the emulsion maintains a pH of about 3.0 to about 6.5. Another patent details a topical gel formulation that includes about 0.5% to about 10% Montelukast, about 0.2% to about 8% cellulose polymer, and about 80% to about 95% amphiphilic compound, with less than 4% water content.

Career Highlights

Throughout his career, Avi Avramoff has worked with prominent companies in the pharmaceutical industry, including Taro Pharmaceutical Industries Limited and Dexcel Pharma Technologies Ltd. His work has significantly impacted the development of effective topical treatments.

Collaborations

Avramoff has collaborated with notable professionals in his field, including Helena Shifrin and Ron Schlinger. Their combined expertise has contributed to the advancement of his innovative formulations.

Conclusion

Avi Avramoff stands out as a key figure in the development of topical pharmaceutical formulations, with a strong portfolio of patents that reflect his innovative spirit. His work continues to influence the industry and improve patient care.